Anika Therapeutics reported $90.98M in Cash and Equivalent for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
Acceleron Pharma XLRN:US $ 336.46M 0.26M
Acorda Therapeutics ACOR:US $ 36.17M 9.55M
Adamas Pharmaceuticals ADMS:US 78.62M 10.17M
Agios Pharmaceuticals AGIO:US $ 400.22M 568.9M
Anika Therapeutics ANIK:US $ 90.98M 6.2M
Arrowhead Research ARWR:US $ 184.43M 141.55M
Chemocentryx CCXI:US $ 93.73M 16.52M
Clovis Oncology CLVS:US $ 171.95M 58.26M
Dicerna Pharmaceuticals DRNA:US $ 165.76M 55.45M
Enanta Pharmaceuticals ENTA:US $ 57.21M 52.6M
Flexion Therapeutics FLXN:US $ 136.82M 29.2M
Halozyme Therapeutics HALO:US $ 491.68M 44.72M
Heron Therapeutics HRTX:US $ 159.57M 31.6M
Immunogen IMGN:US $ 245.76M 6.22M
Insmed INSM:US $ 846.56M 81.77M
Integra Lifesciences IART:US $ 470.23M 72.82M
Intrexon XON:US $ 41.73M 5.32M
Karyopharm Therapeutics KPTI:US $ 137.4M 3.91M
Ligand Pharmaceuticals LGND:US $ 23.43M 1.57M
Macrogenics MGNX:US $ 190.53M 1.56M
Merit Medical Systems MMSI:US $ 68.9M 0.77M
Peregrine Pharmaceuticals PPHM:US $ 163.68M 3.98M
Rigel Pharmaceuticals RIGL:US $ 30.4M 54.42M
Sangamo Biosciences SGMO:US $ 176.95M 7.08M
Stryker SYK:US $ 2563M 322M
Surmodics SRDX:US $ 31.15M 31.02M
Veracyte VCYT:US $ 164.03M 163.52M
Xencor XNCR:US $ 41.2M 74.64M
Zimmer Biomet Holdings Inc ZBH:US $ 919.6M 122.8M